Dabigatran Etexilate Mesylate
Brand name: Dabigatran Etexilate
Rank #211 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$66.0M
Total Cost
220,652
Total Claims
$66.0M
Total Cost
5,505
Prescribers
$299
Cost per Claim
54,850
Beneficiaries
505,974
30-Day Fills
$12K
Avg Cost/Provider
40
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$66.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $66.0M total
Top Prescribers of Dabigatran Etexilate Mesylate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jennifer Tresser | Pharmacist | Martinez, CA | 12,532 | $3.8M |
| 2 | Jordan Wong | Pharmacist | San Francisco, CA | 8,848 | $2.7M |
| 3 | Carmen Wong | Pharmacist | Union City, CA | 8,456 | $2.6M |
| 4 | Cathy Yan-Fang Liang | Pharmacist | Oakland, CA | 1,870 | $564K |
| 5 | Kimberly Gale | Pharmacist | Sacramento, CA | 1,655 | $518K |
| 6 | Juan Alvergue | Internal Medicine | San Marcos, CA | 949 | $282K |
| 7 | Kong Do | Pharmacist | Aurora, CO | 933 | $234K |
| 8 | Katherine Hillblom | Pharmacist | Sacramento, CA | 763 | $232K |
| 9 | Matoo Saluja | Internal Medicine | Woodland Hills, CA | 887 | $232K |
| 10 | Aimee Li | Pharmacist | Panorama City, CA | 673 | $199K |
| 11 | Peng Chen | Pharmacist | Renton, WA | 823 | $188K |
| 12 | Richard Wong | Internal Medicine | Tarzana, CA | 595 | $183K |
| 13 | Leonid Slavin | Internal Medicine | San Diego, CA | 606 | $180K |
| 14 | Deepa Nandyal | Internal Medicine | Roseville, CA | 538 | $161K |
| 15 | Pavittarpaul Dhesi | Cardiology | Los Angeles, CA | 499 | $145K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 208 | Abaloparatide (Tymlos) | $68.4M | 24,417 |
| 209 | Treprostinil Diolamine (Orenitram Er) | $68.2M | 5,964 |
| 210 | Esomeprazole Magnesium (Esomeprazole Magnesium) | $66.3M | 964,193 |
| 211 | Dabigatran Etexilate Mesylate (Dabigatran Etexilate) | $66.0M | 220,652 |
| 212 | Netarsudil Mesylate (Rhopressa) | $65.6M | 129,116 |
| 213 | Risperidone Microspheres (Risperdal Consta) | $64.8M | 47,567 |
| 214 | Venlafaxine Hcl (Venlafaxine Hcl) | $64.7M | 2,187,710 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology